| Name | Title | Contact Details |
|---|
Envision Healthcare, a leading national medical group, focused on investing in the future of health and wellness.
The largest health insurer in the state of Kansas. As a mutual insurance company, BCBSKS is owned by its policyholders. Its board of directors consists of Kansans from different areas of the state, 16 policyholders who bring to the table practical experience in business, medicine, hospital administration and education. Day-to-day operations are directed by a nine-person steering committee under the guidance of the company’s president/CEO. Customers and health care professionals have a voice in company activities through numerous advisory and liaison committees, as well as focus groups and surveys. BCBSKS is a financially secure, billion dollar company that contributes to the Kansas economy in several ways. The company surpasses $1 billion in annual claims payments to health care providers and members and contributes more than $140 million a year to the economy through payroll and taxes. The company's headquarters are located in Topeka, KS. Nearly 1,400 employees work in the company's various office locations in Topeka. In addition, about 110 employees work in offices in Dodge City, Garden City, Hays, Hutchinson, Independence, Lawrence, Manhattan, Pittsburg, Salina and Wichita. BCBSKS is a member of the Blue Cross Blue Shield Association headquartered in Chicago. There are 36 Blue Cross and Blue Shield Plans throughout the United States. Each Plan is separate and independent but all Plans cooperate with other Blue Cross and Blue Shield Plans in the exchange of ideas, processing of claims and providing inter-plan services to customers.
Stephen L. LaFrance, a certified pharmacist, founded the USA Drug family in February 1968. The retail drug store chain now boasts over 110 retail outlets in Tennessee, Mississippi, Missouri, and Arkansas, branded as USA Drug, Super D Drugs and Ike's Deep
Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Delphinus is committed to creating improved imaging methods that assist medical professionals to better define and diagnose breast disease, while establishing a better patient experience that can be available for all women, regardless of age, without the concern of radiation or pain. Headquartered in Plymouth, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Known as SoftVue™, three critical sound characteristics are measured and refined through proprietary algorithms, advancing this technology far beyond traditional b-mode ultrasound. By collecting and defining reflection, sound speed, and attenuation data in a 360° orientation, data are gathered and reconstructed in tomographic coronal planes, providing an enriched image set presented for cross-sectional review. SoftVue has received FDA clearance for diagnostic imaging purposes and is not intended for use as a replacement for screening mammography. Delphinus was formed in 2010 as a spin-out of Karmanos Cancer Institute [KCI] in Detroit, MI. Created by Peter Littrup, MD of Karmanos and Neb Duric, PhD of Wayne State University Detroit, MI the SoftVue technology presents a new imaging paradigm in breast disease assessment. Karmanos Cancer Institute has served as a primary investigational site for case collection and clinical studies. Delphinus holds numerous patents and proprietary assets for its innovative and scientifically-advanced works and is poised to usher in a new era of breast imaging.
Vetoquinol N.-A. Inc is a Lavaltrie, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.